BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21345368)

  • 1. DNA hypermethylation as a chemotherapy target.
    Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
    Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting DNA methylation in cancer.
    Szyf M
    Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; CalabrĂ² L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
    Schneider-Stock R; Ocker M
    IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic drug discovery: targeting DNA methyltransferases.
    Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
    J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies.
    Fahy J; Jeltsch A; Arimondo PB
    Expert Opin Ther Pat; 2012 Dec; 22(12):1427-42. PubMed ID: 23033952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.
    Murgo AJ
    Semin Oncol; 2005 Oct; 32(5):458-64. PubMed ID: 16210086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methyltransferase inhibitors for cancer therapy.
    Brueckner B; Kuck D; Lyko F
    Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and cancer treatment.
    Kristensen LS; Nielsen HM; Hansen LL
    Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivating the expression of methylation silenced genes in human cancer.
    Karpf AR; Jones DA
    Oncogene; 2002 Aug; 21(35):5496-503. PubMed ID: 12154410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting DNA methylation with small molecules: what's next?
    Erdmann A; Halby L; Fahy J; Arimondo PB
    J Med Chem; 2015 Mar; 58(6):2569-83. PubMed ID: 25406944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of DNA methyltransferase enzymes as a novel strategy for cancer treatment.
    Reid GK; Besterman JM; MacLeod AR
    Curr Opin Mol Ther; 2002 Apr; 4(2):130-7. PubMed ID: 12044034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic tools in potential anticancer therapy.
    Sebova K; Fridrichova I
    Anticancer Drugs; 2010 Jul; 21(6):565-77. PubMed ID: 20436342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation: a new research area for melatonin?
    Korkmaz A; Reiter RJ
    J Pineal Res; 2008 Jan; 44(1):41-4. PubMed ID: 18078446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches on epigenetics.
    Papait R; Monti E; Bonapace IM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.